In 2023, the total value of liabilities held by ToolGen amounted to around 63.4 billion South Korean won. This represents a significant increase compared to the previous year. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.
Total liabilities of ToolGen from 2013 to 2023
(in billion South Korean won)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
DART. (March 29, 2024). Total liabilities of ToolGen from 2013 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1394298/toolgen-total-liabilities/
DART. "Total liabilities of ToolGen from 2013 to 2023 (in billion South Korean won)." Chart. March 29, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1394298/toolgen-total-liabilities/
DART. (2024). Total liabilities of ToolGen from 2013 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1394298/toolgen-total-liabilities/
DART. "Total Liabilities of Toolgen from 2013 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 29 Mar 2024, https://www.statista.com/statistics/1394298/toolgen-total-liabilities/
DART, Total liabilities of ToolGen from 2013 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/1394298/toolgen-total-liabilities/ (last visited November 21, 2024)
Total liabilities of ToolGen from 2013 to 2023 (in billion South Korean won) [Graph], DART, March 29, 2024. [Online]. Available: https://www.statista.com/statistics/1394298/toolgen-total-liabilities/